Toshio Fujimoto

Toshio Fujimoto
Toshio Fujimoto MBA, MD is the General Manager of Shonan Health Innovation Park (iPark) since April 2018. In his current role, Dr Fujimoto provides strategic leadership and oversight for all key iPark activities. He implements the iPark’s vision to be an open innovation ecosystem which builds meaningful collaborations with academia, biotech, pharma companies, and the government. Dr Fujimoto received his MD from Kyoto University and his MBA from Kobe University. He began his clinical practice as a Resident at the Department of Thoracic Surgery at Kyoto University Hospital. After completing several rotations at local area hospitals, he took a position …
Toshio Fujimoto MBA, MD is the General Manager of Shonan Health Innovation Park (iPark) since April 2018. In his current role, Dr Fujimoto provides strategic leadership and oversight for all key iPark activities. He implements the iPark’s vision to be an open innovation ecosystem which builds meaningful collaborations with academia, biotech, pharma companies, and the government.

Dr Fujimoto received his MD from Kyoto University and his MBA from Kobe University. He began his clinical practice as a Resident at the Department of Thoracic Surgery at Kyoto University Hospital. After completing several rotations at local area hospitals, he took a position in Germany as an Assistant Surgeon with the Thoracic Surgery Department at Ruhrlandklink Hospital, and later moved to the US to serve as Clinical Fellow, General Thoracic Surgery at the Mayo Clinic.

Prior to joining Shonan iPark, Dr Fujimoto held positions with increasing responsibility at Eli Lilly Japan. Most recently he was Vice President of the Medicine Development Unit, where he oversaw the R&D Management function in Japan.
See more

Articles: Toshio Fujimoto

Life Science VC Funding in Japan: Signs of Growth & Untapped Opportunities

Japan / Toshio Fujimoto, MD, MBA, the General Manager of Shonan Health Innovation Park examines why Japan – despite being well established as one of the world’s most innovative and technologically advanced countries – has lagged behind in terms of VC funding, especially in the life sciences and how this can be rectified.   Japan has long…

San Diego: What it Takes to be a Successful Life Science Innovation Centre

Global / Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020 conference on why San Diego offers a good example of what it takes to be a leader in the innovative life science sector.   Over the past two decades, drug discovery has undergone a fundamental transformation from an…

Japan: The Latest Therapeutic Applications in Induced Pluripotent Stem Cell (iPSC) Technology

Japan / Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan over a decade ago is poised to drive major medical advances and new treatments.   Here’s what we know today and what we’ll need to do tomorrow to benefit from the promises of iPCS.   Induced pluripotent…

Japan Market Entry: Opportunities & Challenges

Japan / Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park, gives an insider’s take on the opportunities and challenges for pharma companies in the large, innovation-friendly, but often misunderstood, Japanese market.   Japan is the world’s third-largest economy and second-largest pharmaceutical and medtech market, and yet it still holds a reputation as a difficult business…

Maintaining Open Innovation in Our ‘New Normal’ Through Virtual Collaboration

Japan / Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that make our lives easier while enabling us to maintain a culture of innovation and growth.   Are social distancing requirements causing the life science industry to return to an inward-looking culture of secrecy? The short answer is no…

See more